Eugenia Girda, MD, FACOG, discusses the use of pembrolizumab plus chemotherapy for patients with endometrial cancer as seen in the phase 3 NRG-GY018 trial.
Eugenia Girda, MD
Advertisement
Articles by Eugenia Girda, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Tegavivint Plus Osimertinib Shows Early Activity in First-Line EGFR-Mutated NSCLC
2
FDA Grants Final Approval to Lutetium Lu 177 Dotatate Biosimilar for SSTR+ GEP-NETs
3
FDA Approves Generic Lanreotide Injection for GEP-NETs
4
FDA Flashback: Breast Cancer Decisions and News From August 2026
5